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Abstract 
Background
Vascular stents are small tubular scaffolds used in the treatment of arterial stenosis
(narrowing of the vessel). Most vascular stents are metallic and are deployed either by 
balloon expansion or by self-expansion. A shape memory polymer (SMP) stent may 
enhance flexibility, compliance, and drug elution compared to its current metallic 
counterparts. The purpose of this study was to describe the fabrication of a laser-
activated SMP stent and demonstrate photothermal expansion of the stent in an in 
vitro artery model.
Methods
A novel SMP stent was fabricated from thermoplastic polyurethane. A solid SMP 
tube formed by dip coating a stainless steel pin was laser-etched to create the mesh 
pattern of the finished stent. The stent was crimped over a fiber-optic cylindrical light 
diffuser coupled to an infrared diode laser. Photothermal actuation of the stent was 
performed in a water-filled mock artery.
Results
At a physiological flow rate, the stent did not fully expand at the maximum laser 
power (8.6 W) due to convective cooling. However, under zero flow, simulating the 
technique of endovascular flow occlusion, complete laser actuation was achieved in 
the mock artery at a laser power of ~8 W.
Conclusions
We have shown the design and fabrication of an SMP stent and a means of light 
delivery for photothermal actuation. Though further studies are required to optimize 
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the device and assess thermal tissue damage, photothermal actuation of the SMP stent 
was demonstrated.
Background 
Vascular stents are small tubular scaffolds used to maintain the luminal size of an 
artery. They are now widely used in conjunction with transluminal angioplasty in the 
treatment of arterial stenosis (narrowing of the vessel) to prevent acute vessel closure 
and late restenosis in a variety of large vessels such as coronary arteries [1], carotid 
arteries [2], and iliac arteries [3]. Most stents are currently made of stainless steel, 
shape memory alloys (SMAs), and other metal alloys. Crimped over a catheter, they 
are navigated to the lesion site where they are expanded either by balloon expansion 
or by self-expansion. Though improvements in design and coating with drug-eluting 
agents have resulted in smaller, safer, and more biocompatible stents with reduced 
rates of restenosis [4], several drawbacks associated with the use of metallic stents 
still exist. First, metallic stents are too stiff to navigate highly tortuous vessels such as 
those of the neurovasculature; the need for treatment of stroke and intracranial 
stenosis is well known [5], but successful stenting with the current technology has 
been shown in a limited number of cases only [6]. Second, compliance mismatch due 
to the stiffness of metallic stents at the arterial wall may potentially be a contributing 
factor in restenosis based on trapped proliferating cells observed for a stent with 
compliance-matched ends [7]. Third, drug elution is currently achieved by coating the 
metal with a drug-doped polymer [8], which requires a costly additional fabrication 
step [9].  
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Thermally activated shape memory polymer (SMP) is a unique class of polymeric 
materials that can maintain a secondary shape and then recover a pre-determined 
primary shape when sufficiently heated. SMP has been shown to have promising 
applications in intravascular medical devices for thrombectomy [10,11], aneurysm 
embolization [12,13], and as vascular stents [14]. Our previous investigation of the 
thermomechanical properties of shape memory polyurethane revealed high recovery 
strains, which are needed for large shape changes during stent deployment [15]. In 
addition, the glassy modulus of SMP is lower than those of SMAs and stainless steel 
by a factor of at least 10 and 100, respectively, potentially yielding a more flexible 
and compliant structure depending on the amount of material and the stent design 
pattern [16]. Ongoing biocompatibility studies have shown that the material has 
minimal effect on triggering an inflammatory response, activating platelets and 
neutrophils, and inducing thrombogenesis in vitro [17]. Finally, drug embedding in 
polymer stents has already been demonstrated [18]. Thus, the large strain recovery, 
flexibility, conformability, and compliance of SMPs could overcome the problems 
encountered with current metallic vascular stents. 
Light absorption has been shown to be an effective heating mechanism for actuating
SMPs [10,11,19,20]. In this paper, we present a photothermally activated self-
expanding stent made of shape memory polyurethane. The SMP stent is crimped over 
a light diffuser attached to the end of an optical fiber coupled to an infrared diode 
laser. The optical fiber serves as both the transport vehicle and the conduit for light 
energy delivery to the stent. We describe the design and fabrication of the device and 
demonstrate laser actuation in a water-filled in vitro artery model.
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Methods
Shape memory polymer
The SMP used in this study was MM5520 thermoplastic polyurethane; it was obtained 
from DiAPLEX Company, Ltd. (a subsidiary of Mitsubishi Heavy Industries Ltd., 
Tokyo, Japan) in the form of pellets. The composition is proprietary, but it is known 
that the material is a segmented polyurethane with a microphase separated 
morphology consisting of a hard phase and a soft phase [21]. The nominal 
temperature of the soft phase glass transition (Tg) was 55 °C. The shape memory 
effect comes from the entropic potential for recovery of the primary shape, stored in 
macromolecular chains of the soft phase in the secondary shape. The primary shape 
can be formed by heating the material above the hard phase glass transition 
temperature, deforming the material into the desired shape, and then cooling to fix the 
shape. Alternatively, the material may be dissolved in a suitable solvent and cast in a 
mold or coated onto a surface (as was done in this study) and vacuum dried to 
establish the primary shape. The secondary shape is obtained by heating the material 
above Tg, deforming the material (in this case crimping), and cooling to fix the shape. 
Heating the material again to Tg results in recovery of the primary shape. Due to the 
broad soft phase glass transition of MM5520 [11], shape recovery begins to occur at 
40-45 °C (10-15 °C below the nominal Tg of 55 °C). The material exhibits different 
mechanical properties above and below the Tg. Our previous studies of this specific 
polymer have shown a glassy modulus of ~800 MPa (shear modulus at Tg-25 °C), and 
a rubbery modulus of ~1.4 MPa (shear modulus at Tg+25 °C) [15]. The glassy 
modulus of this SMP (~800 MPa) lies in the range of reported values for balloon-
expandable polymer stents, which starts at 400 MPa (for applications requiring low 
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mechanical strength, such as neural stenting) and extends up to 7 GPa [22]. 
Accordingly, the relatively low glassy modulus (and, hence, low expansion force) of 
the SMP stent may require balloon angioplasty prior to laser expansion.
Device fabrication
Fabrication of the stent began by dissolving pellets of MM5520 in tetrahydrofuran 
(THF) to prepare a solution with a composition of 17.5% by weight of polymer in 
solvent. A SMP tube was first made by dip coating a 4 mm diameter stainless steel 
pin in the solution multiple times at a constant rate of withdrawal. The coated pin was 
then dried for 24 hours at 50 °C under vacuum. After cooling, the SMP tube was laser 
etched to impart a specific pattern based on an imported CAD file using a computer-
controlled system. As shown in Fig. 1(a), solid rings are connected by S-shaped struts, 
enhancing its longitudinal flexibility. The stent was then removed from the pin using 
hot water, dried, doped with a laser-absorbing platinum dye (Epolight 4121, Epolin, 
Inc.), and dried again for 24 hours at 50 °C under vacuum. The dye was incorporated 
by coating the stent with a solution of 4440 ppm dye in THF. The stent diameter 
decreased slightly after removal from the pin due to residual stress in the SMP. The 
final stent in its expanded state was 4.1 mm outer diameter by 16 mm long with a wall 
thickness of 250 μm.
The light delivery/transport vehicle assembly consisted of two main components, both 
of which were fabricated using SMP: (1) a 300 μm diameter by ~16 mm long 
cylindrical light diffusing SMP rod attached to the end of an optical fiber and (2) a 
coaxial 5 mm diameter by ~16 mm long SMP foam cylinder surrounding the diffusing 
rod. This assembly was inserted inside the stent lumen prior to crimping (Fig. 1(a,c)). 
The diffuser was fabricated by casting an SMP formulation developed in-house [23]
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over the distal end of a 100 μm core diameter silica optical fiber (FIP100110125, 
Polymicro Technologies, LLC) using a tubular mold made of Teflon. To enable light 
diffusion, the surface of the cured SMP cylinder was abraded using a media blaster 
loaded with sodium bicarbonate powder. The longitudinal emission profile of the 
diffuser, acquired using a CCD camera with the optical fiber coupled to a red 4.2 mW 
diode laser, is shown in Fig. 1(d). Approximately 80% of the incident laser light was 
emitted in the first centimeter of the diffuser. The optical fiber was sheathed with a 
711 μm outer diameter stainless steel hypotube to provide a pushable transport 
vehicle.
The foam component was made of in-house formulated SMP material consisting of 
hexamethylene diisocyanate (HDI), N,N,N’-tetrakis(2-
hydroxypropyl)ethylenediamine (HPED), and triethanolamine (TEA) [13]. The 
density of the foam was 0.020 g/cm3 with mostly open cells approximately 200 μm in 
size (determined by optical microscopy). The calculated volumetric void fraction was 
98.4%, which would allow a theoretical expansion of 60 times from the fully 
condensed state. Differential scanning calorimetry measurements showed a Tg around 
40 °C. The foam cylinder was cut using a 5 mm biopsy punch and then slightly 
compressed under warm air to enable it to fit inside the expanded stent. The role of 
the foam cylinder is to assist photothermal expansion of the device by (1) centering 
the diffuser in the stent lumen, (2) increasing laser light scattering to improve 
illumination uniformity, and (3) reducing convective cooling of the stent. Though not 
necessary in this initial prototype, the foam would be bonded to the diffuser to 
facilitate withdrawal after stent deployment in a clinical device.
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With the diffuser/foam assembly positioned inside the stent lumen as shown in Fig. 
1(a,c), the final device was mechanically compressed using a crimping machine 
(Balloon Wrapping Fixture Model W8FH, Interface Associates, Inc.) from 4.1 mm 
down to 1.8 mm (smaller diameters are possible depending on the amount of material 
and stent design). The machine consists of eight radially arranged heated blades 
which form a cylindrical cavity; as the blades move inward, the cavity diameter 
decreases. The blades were heated to 88 °C prior to and during compression, and then 
cooled to room temperature before the crimped device was removed. The device 
remained in the crimped shape before experimental actuation. Fig. 1(b) shows the 
device in its crimped state.
Artery model and device actuation
An artery model consisting of a straight mock artery in a chamber was built in-house. 
The mock artery (4 mm inner diameter, 150 μm wall thickness, 4 cm length) was 
made of a silicone elastomer (Sylgard 184, Dow Corning) prepared by dip coating 
pins in a similar manner as the stent. As shown in Fig. 2, two stainless steel cylinders 
hold the mock artery in place inside the chamber; water at a desired temperature can 
be pumped independently in the outer chamber and into the mock artery. A 
thermocouple probe allows temperature reading in the outer chamber. A Touhy Borst 
valve allows flow of water and delivery of the device into the mock artery. Water 
temperature in the outer chamber and in the mock artery was maintained at 37 °C 
(body temperature). After coupling the optical fiber to an 810 nm diode laser 
(UM7800/100/20, Unique Mode), the device was delivered into the mock artery and 
photothermally actuated.
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Results 
After delivery to the mock artery, the stent did not show signs of expansion in the 37
°C water for approximately 3 min prior to actuation. This indicates that the device 
would likely remain crimped during navigation and positioning under physiological 
conditions until it is controllably expanded, though further investigation is needed to 
confirm this hypothesis. Fig. 3 shows the device being actuated under zero flow as the 
laser power was slowly increased from 0 to 8.6 W in 1 W increments over 6.3 min (a 
time lapse video is provided in additional file 1: stent video.avi). The laser power 
could be increased more rapidly or kept constant in an optimized actuation protocol to 
reduce the actuation time. The end of the stent closer to the tip of the optical fiber 
rapidly expanded at a power of 1 W, consistent with the stronger proximal emission 
of the diffuser. The remainder of the stent fully expanded at ~8 W. The temperature 
inside the outer chamber did not vary during actuation, as indicated by the 
thermocouple probe. Following actuation, the diffuser was withdrawn and the stent 
and inner foam were retrieved from the mock artery by disassembling the chamber. 
The stent, foam, diffuser, and mock artery showed no visible signs of thermal 
damage. The experiment was repeated two more times with similar results.
In two separate attempts, the stent expanded only about 60% during actuation at 8.6 
W for several minutes when the flow rate was increased to 180 ml/min, a value in the 
range of reported flows in the internal carotid artery [24]. This result suggests that the 
laser heating was overcome by convective cooling before full expansion was 
achieved.
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Discussion 
In an actual clinical intervention, the inner foam would need to be withdrawn with the 
diffuser. As mentioned previously, one way to achieve this would be to bond the foam 
to the diffuser. Because the foam (Tg ~ 40 °C) is compliant at body temperature, it can 
conform to the smaller diameter of the delivery catheter as it is pulled back for 
removal from the body. Tapering the proximal end of the foam may facilitate 
retraction back into the delivery catheter.
Due to the different physical properties of water and blood [25-30] (see Table 1), heat 
transfer between the laser-heated stent and the surrounding fluid is not necessarily 
identical for the two fluids. The difference was assessed for the two flow cases 
investigated: (1) zero flow and (2) physiological flow (180 ml/min). In the zero flow 
case, heat transfer occurs by conduction and natural convection. Because the thermal 
diffusivity of water is similar to that of blood, heat transfer by conduction is expected 
to be similar for the two fluids. Heat transfer by natural convection was assessed by 
estimating the Nusselt number (Nu), which represents the ratio of total heat transfer to 
conductive heat transfer. In the zero flow case for two concentric cylinders (collapsed 
stent centered in the mock artery), Nu for natural convection is given by [31]
( )
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where lC is given by [31]
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+
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and Do is the diameter of the outer cylinder (mock artery inner diameter = 0.004 m), 
Di is the diameter of the inner cylinder (collapsed stent diameter = 0.0018 m), L is the 
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gap between the cylinders (0.0011 m), Ra is the Rayleigh number, and Pr = ν/α is the 
Prandtl number [26]. Ra is given by [31]
( )
na
b 3LTTgRa oi -=
where g is gravity (9.81 m/s2), Ti is the temperature of the inner cylinder (stent 
temperature ~ Tg = 55 °C) and To is the temperature of the outer cylinder (body 
temperature = 37 °C). Nu was calculated to be 1.8 for water and 1.6 for blood, 
indicating that heat transfer in the zero flow case is similar for the two fluids.
In the case of physiological flow, forced convection is the dominant heat transfer 
mechanism, though it depends on the flow characteristics. The flow is characterized 
by the Reynolds number (Re) given by [32]
( ) nio DDU -=Re
where U is the flow velocity around the collapsed stent in the mock artery at the 
physiological flow rate of 180 ml/min (0.3 m/s). Re was calculated to be 940 for 
water and 200 for blood, values that are below the critical Re of ~2000 corresponding 
to the onset of turbulence in a circular tube [26]. For laminar flow between two 
concentric cylinders with Di/Do = 0.45, Nu ≈ 6 for both fluids [33]. Based on these 
estimates, heat transfer in water is similar to that of blood for both the zero and non-
zero flow conditions in this study.
Due to their different values of absorption coefficient (μa) near the laser wavelength 
of 810 nm, photothermal actuation of the stent will proceed differently in water (μa = 
0.0021 mm-1 [34]) than blood (μa = 0.466 mm-1 [35]). Initially, light emitted from the 
diffuser will reach the stent without encountering the fluid. However, as expansion 
- 12 -
continues the fluid can migrate into the pores of the inner foam cylinder. Ignoring the 
foam, the absorption mean free path (i.e., average distance a photon will travel before 
being absorbed) for water is 1/μa = 476 mm; therefore, nearly all the emitted light will 
reach the stent throughout its expansion. For blood, the absorption mean free path is 
2.1 mm, which is approximately equal to the radius of the fully expanded stent (note 
that scattering in blood is highly forward-directed with the average cosine of the 
scattering angle = 0.98 [36]). The percentage of light transmitted T to the expanding 
stent of radius r is given by T = 100exp(-μar); T = 39% for r = 2 mm (fully expanded). 
The probability that a photon will be absorbed by the blood prior to reaching the stent 
is higher than that for water; however, photons that are absorbed will locally heat the 
blood, which will, in turn, help heat the stent. For example, in the case of zero flow, 
the blood temperature rise due to absorption can be estimated by ΔT  ≈ Pabst/cρV, 
where Pabs is the absorbed laser power (~ 100-39 = 61% of the emitted light, ignoring 
absorption by the stent), t is the laser duration in seconds, c and ρ are the specific heat 
and density, respectively, of blood (see Table 1), and V is the volume of blood in the 
vicinity of the stent (~2.5×10-7 m3 for a 4-mm-diameter artery). This estimate assumes 
the heat load is evenly distributed in the blood volume and does not include heat 
losses to the blood and arterial wall adjacent to the heated volume. At the maximum 
laser power in this study, Pabs ≈ 5 W and the blood temperature (ΔT+37 °C) would 
reach the SMP Tg of 55 °C within 4 s. Accordingly, laser power and dye 
concentration in the stent may require adjustment relative to values suitable for use in 
water. Though laser actuation of the stent in blood is feasible in principle, 
experimental verification using blood is a necessary future step in the device 
development process.
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Though in vitro biocompatibility studies analyzing immunostimulatory and 
thrombogenic properties of SMP are encouraging [17], other potential adverse effects 
of implantation (e.g., effect on renal function) and increased temperature due to 
thermal actuation are unknown and require additional study. In addition, the 
biocompatibility of the SMP doped with the laser-absorbing platinum dye has not 
been tested. If concerns were to arise based on such testing, a known biocompatible 
dye such as indocyanine green (ICG) could be used in place of the platinum dye. ICG 
is routinely administered intravenously as a contrast agent in retinal angiography, and 
has an absorbance band centered near the laser wavelength of 810 nm. ICG has been 
used to increase the laser absorption of SMP for photothermal actuation in previous 
work [11].
In addition to light absorption, various heating mechanisms may be employed for 
thermally activated SMP devices including electrical (Joule) heating [20,37,38], 
inductive heating [39], and heated fluid flush. For the stent application, light 
absorption provides a means of efficient localized heating of the dye-doped device, 
and the cylindrical geometry of the device is well-suited to illumination by a 
cylindrical light diffuser. In addition, the lack of physical connection between the 
light diffuser and the device enables the stent to expand freely. Inductive heating of a 
device doped with appropriate magnetic particles would also provide remote, 
localized heating, though such a device would require development of a clinically safe
external source of alternating magnetic field. Localized Joule heating could be applied 
by embedding resistive heating elements (e.g., wires) into the device (though such
elements must not interfere with shape recovery) or employing a conductive SMP 
composite material [20] and passing a current through the device; in either case, the 
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stent would be physically connected to the power source and would have to be 
detached from the leads supplying the current following device deployment. Flowing 
heated saline through the delivery catheter either using a heated reservoir or 
embedding heating elements in the delivery catheter would expose a larger area of the 
vessel to elevated temperatures, which may or may not be detrimental.
Another option for SMP device deployment is to employ a low-Tg material (≤37 °C) 
such that the device spontaneously actuates at body temperature. Such a stent would 
not require an external heating source, and therefore would not raise the concern of 
thermal tissue damage. However, the modulus of the SMP at or above Tg (~1-10 
MPa) [11] is at least an order of magnitude lower than the modulus values of 
polymers typically used for stents in previous work [22]. Nevertheless, the fact that 
the SMP stent would not permanently deform if compressed (e.g., during arterial 
spasm), unlike some metallic stents, suggests that further study of such a design may 
be warranted. One group has reported complete shape recovery of prototype SMP 
stents designed to expand at body temperature, noting that the recovery can be 
controlled by varying the glass transition temperature, polymer crosslink density, and 
stent geometry [40].
Photothermal actuation introduces the potential to cause thermal damage to tissue and 
blood in the vicinity of the device. While we did not measure the temperature of the 
stent, the fact that the stent fully actuated indicated that it at least approached the Tg of 
the stent (55 °C). The temperature around the device depends on the cooling capacity 
of the blood and tissue, the laser power and duration, light absorption by the blood, 
tissue, and device, and blood flow. Thermal damage depends on the time-temperature 
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history. For example, according to an Arrhenius damage model for arterial collagen 
denaturation [41], it would require several hours at a temperature of 55 °C to induce 
irreversible damage, a timescale much longer than that needed for photothermal stent 
expansion. A similar model for arterial endothelial cell damage [42] indicates that cell 
damage would occur in less than a second at 55 °C. However, standard intravascular 
catheter insertion and manipulation, as is used in conventional stent placement, is also 
known to damage the endothelial cell layer [43]. Following acute injury (mechanical 
or thermal) to the vessel wall and/or endothelial layer, long-term arterial recovery has 
been shown [44,45]. In vivo survival studies including histology at acute and long-
term time points are required to assess the extent and tolerance of potential thermal 
damage caused by photothermal actuation of the SMP stent.
In practice, stents are generally placed under blood flow; however, certain other 
medical interventional devices, such as the MERCI Retriever for clot extraction in 
cerebral arteries [46], incorporate a protection mechanism to block blood flow during 
the intervention. The advantage of delivering the laser-activated SMP stent under a 
zero flow condition is that identical operating parameters (e.g., laser power and 
duration) can be used regardless of the flow conditions in the target vessel. In 
addition, by minimizing convective cooling, it reduces the amount of laser energy 
needed to achieve expansion.
Whether it will be clinically delivered with flow or without flow, this first prototype 
needs to be optimized for a controlled full actuation without causing detrimental 
thermal injury to the surrounding artery. Optimization could include systematically 
adjusting the dye concentration in the stent, possibly incorporating dye into the foam, 
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improving the uniformity of emission along the length of the diffuser by modifying 
the media blasting parameters, and adjusting the foam density to enhance light 
scattering. In addition, the Tg of the stent and foam can also be varied by using a 
different SMP material or by varying the fabrication conditions [14,15]. The Tg
should be tailored to be low enough such that the stent can be actuated at the lowest 
possible laser power, but it should be high enough such that the stent does not self-
expand at body temperature (37 °C). The current prototype was designed for use in a 
large vessel such as the internal carotid artery, not in the narrow cerebral vasculature. 
The stent pattern and dimensions would need to be scaled down to enable the device 
to be crimped down sufficiently for intravascular catheter delivery.
Conclusions 
We have shown the design and fabrication of a novel laser-activated stent made of 
shape memory polymer. In addition, we developed a fiber optic-based means of light 
delivery for photothermal actuation. Though further studies are required to optimize 
the device and assess potential thermal tissue damage, preliminary in vitro testing
demonstrated the concept of intravascular photothermal deployment of an SMP stent.
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Figures
Figure 1  - SMP stent
Close-up of the SMP stent mounted over the SMP foam cylinder (black arrow) and 
the coaxial SMP diffuser (white arrow) prior to crimping (a) and after crimping (b). 
The distal end of the stainless steel hypotube containing the optical fiber is indicated 
by the asterisk in (a). An image of the diffuser emission, which decreases with 
distance from the optical fiber tip, is shown in (c). A cross-sectional diagram of the 
expanded stent with the diffuser and foam cylinder in place is shown in (d).
Figure 2  - Artery model
Schematic of the artery model. WB: water bath, PP: peristaltic pump, TB: Touhy 
Borst valve, SS: stainless steel cylinder, OC: outer chamber, TC: thermocouple probe, 
MA: mock artery.
Figure 3  - Stent deployment
Timeline of SMP stent deployment in the mock artery (zero flow) as the laser power 
was gradually increased. Laser duration was approximately 6.3 min.
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Tables
Table 1 - Physical properties of water and blood
Property Water Blood Units
density ρ 1000 1050 [25] kg/m3
specific heat c 4190 [26] 3850 [25] J/(kg · K)
thermal conductivity k 0.61 [27] 0.53 [28] W/(m · K)
thermal diffusivity α = k/ρc 1.4×10-7 1.3×10-7 m2/s
absolute viscosity μ 7×10-4 [26] 3.5×10-3 [29] Pa · s
kinematic viscosity ν = μ/ρ 7×10-7 3.3×10-6 m2/s
coefficient of thermal 
expansion β
2.1×10-4 [26] 4.0×10-4 [30] K-1
Additional files
Additional file 1 – stent video.avi
Time lapse video of SMP stent deployment in the mock artery (zero flow) as the laser 
power was gradually increased (see Fig. 3).
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